Akero Therapeutics, Inc.
AKRO
$48.31
$0.280.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.51M | -70.73M | -70.02M | -72.71M | -55.99M |
| Total Depreciation and Amortization | -- | -- | 15.00K | 1.00K | 1.00K |
| Total Amortization of Deferred Charges | 186.00K | 178.00K | 174.00K | 164.00K | 157.00K |
| Total Other Non-Cash Items | 6.39M | 6.49M | 4.13M | 3.92M | 5.26M |
| Change in Net Operating Assets | 15.68M | -3.61M | -1.39M | -1.80M | -6.88M |
| Cash from Operations | -48.25M | -67.66M | -67.09M | -70.42M | -57.45M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -999.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.34M | -482.18M | 15.27M | 73.07M | -254.90M |
| Cash from Investing | 79.34M | -482.18M | 15.27M | 73.07M | -255.90M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.43M | 396.11M | 76.02M | 3.13M | 327.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -576.00K | -29.00K | -64.00K | -477.00K |
| Cash from Financing | 3.43M | 395.53M | 75.99M | 3.07M | -150.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.53M | -154.32M | 24.17M | 5.71M | -313.50M |